Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propene SCHEMBL27946362 | 0.95 | CA1 (0.36) | HPGDTSHRHCAR2CA1CA2 | |
| Hexyl Formate SCHEMBL27946361 | 0.93 | CA1 (0.37) | TSHRHCAR2CA1CA2 | |
| Butyl Formate SCHEMBL1691794 | 0.91 | ATM (0.36) | HPGDTSHRHCAR2ATMMAPT | |
| Butyl Formate SCHEMBL4438325 | 0.89 | ATM (0.35) | HPGDTSHRHCAR2ATMMAPT | |
| Hexyl Formate SCHEMBL4879088 | 0.85 | CA1 (0.41) | HCAR2CA1CA2 | |
| Hexane SCHEMBL27786499 | 0.83 | CA1 (0.36) | TSHRHCAR2ATMMAPTRAB9A | |
| Butyl Formate SCHEMBL28056787 | 0.83 | ATM (0.43) | HPGDTSHRHCAR2ATMMAPT | |
| Propylformate SCHEMBL27856733 | 0.81 | HCAR2 (0.33) | HCAR2CA1CA2 | |
| Butyl Formate SCHEMBL27835010 | 0.81 | ATM (0.45) | HPGDTSHRHCAR2ATMMAPT | |
| Butyl Formate SCHEMBL18813685 | 0.80 | ACHE (0.39) | MAPTNPSR1ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103433145-B | Use the method for the beneficiation of mineral ore bodies of dithiocarbamate collector | CYTEC TECH CORP (US) | 2015-08-12 | — | — | CN | claimed |
| CN-101605608-B | Dithiocarbamate collectors and their use in mineral processing | CYTEC TECH CORP | 2014-03-12 | — | — | CN | claimed |
| CN-103433145-A | Novel dithiocarbamate collectors and their use in the beneficiation of mineral ore bodies | CYTEC TECH CORP | 2013-12-11 | — | — | CN | claimed |
| EP-2117718-B1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES | CYTEC TECH CORP (US) | 2017-05-10 | — | — | EP | disclosed |
| US-8376142-B2 | Dithiocarbamate collectors and their use in the beneficiation of mineral ore bodies | CYTEC TECHNOLOGY CORP. (US) | 2013-02-19 | — | — | US | disclosed |
| US-20080185317-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES | CYTEC TECHNOLOGY CORP. | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080185317-A1 | NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES | FTH1, FECH, SLC40A1 | HPGD 3739/4885TSHR 696/4885HCAR2 3954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.